ATC code M04

ATC code M04 is a section of the Anatomical Therapeutic Chemical Classification System (ATC), which is used for the classification of drugs and other medicinal products. ATC code M04 includes agents that are primarily used to treat gout and hyperuricemia. This category is subdivided into several groups based on the type of drug and its specific therapeutic use.

Structure

The ATC code M04 is divided into the following subgroups:

• M04A - Antigout preparations
• M04B - Uricosurics
• M04C - Preparations inhibiting uric acid production

M04A - Antigout preparations

This subgroup includes drugs that are used to treat acute attacks of gout, such as colchicine, which is derived from the plant Colchicum autumnale. These medications work by reducing the inflammation and pain associated with gout attacks.

M04B - Uricosurics

Uricosurics are drugs that increase the excretion of uric acid in the urine, thus lowering the levels of uric acid in the blood. Common drugs in this category include probenecid and sulfinpyrazone.

M04C - Preparations inhibiting uric acid production

This subgroup contains drugs that reduce the production of uric acid, such as allopurinol and febuxostat. These medications are typically used in the long-term management of gout and hyperuricemia to prevent gout attacks.

Usage

Drugs classified under ATC code M04 are primarily used in the treatment of gout, a form of arthritis characterized by sudden, severe attacks of pain, redness, and tenderness in joints. The choice of medication and treatment regimen depends on the severity of the condition, frequency of attacks, and the presence of any co-existing medical conditions.

See also

• Gout
• Hyperuricemia
• Arthritis
• Pharmacology

   This article is a medical stub. You can help WikiMD by expanding it!